![Quiver Logo](/static/img/logo-icon.png)
![ASRT logo](https://quiver-logos.s3.us-east-2.amazonaws.com/asrt.png)
Assertio Holdings, Inc. Common Stock
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ASRT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of ASRT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ASRT's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to ASRT
Recent picks made for ASRT stock on CNBC
ETFs with the largest estimated holdings in ASRT
Flights by private jets registered to ASRT
![Quiver Logo](/static/img/logo-icon.png)